title: Should New Zealand introduce nationwide pulse oximetry screening for the detection of critical congenital heart disease in newborn infants?
authors.affiliation: Neonatologist and Research Fellow, Liggins Institute, University of Auckland, Auckland.
authors.forename: Elza
authors.initials: E
authors.lastname: Cloete
authors.affiliation: Paediatric Cardiologist and Service Clinical Director, Green Lane Paediatric and Congenital Cardiac Service, Starship Children's Health, Auckland.
authors.forename: Thomas L
authors.initials: TL
authors.lastname: Gentles
authors.affiliation: Neonatologist and Senior Lecturer, Department of Paediatrics: Child and Youth Health, University of Auckland, Auckland.
authors.forename: Jane M
authors.initials: JM
authors.lastname: Alsweiler
authors.affiliation: Midwifery Advisor, New Zealand College of Midwives, Christchurch.
authors.forename: Lesley A
authors.initials: LA
authors.lastname: Dixon
authors.affiliation: Director Newborn Metabolic Screening Programme and Lead Clinical Scientist Antenatal Screening for Down Syndrome and Other Conditions, LabPlus, Auckland City Hospital, Auckland.
authors.forename: Dianne R
authors.initials: DR
authors.lastname: Webster
authors.affiliation: Senior Lecturer, School of Nursing, University of Auckland, Auckland.
authors.forename: Deborah L
authors.initials: DL
authors.lastname: Rowe
authors.affiliation: Professor of Neonatology and Director, Liggins Institute, University of Auckland, Auckland.
authors.forename: Frank H
authors.initials: FH
authors.lastname: Bloomfield
mesh_terms: D006330:Heart Defects, Congenital / Q000175:diagnosis*; D006801:Humans; D007231:Infant, Newborn; D015997:Neonatal Screening / Q000379:methods*; D009520:New Zealand; D010092:Oximetry / Q000379:methods*